Summary • Verrica Pharmaceuticals (VRCA) dropped 11% in pre-market trading to $6.72, with no new catalysts driving the move.• The company recently announced a $50 million private placement to retire ...

Summary • Kyverna Therapeutics (KYTX) shares fell 7% pre-market to $10.04 following a public offering announcement.• The company proposed a $100 million offering, with an additional $15 million option ...

Summary • Trinseo PLC’s stock rises 9% to $0.6000 in pre-market trading amid NYSE compliance concerns.• The NYSE issued a ...

Summary • Ryde Group Ltd. (RYDE) shares rose 9% pre-market to 0.4800 following the announcement of strategic expansion into ...

Summary • Pulse Biosciences, Inc (PLSE) shares rise 8.8% in pre-market trading, reaching $15.37.• The company initiates a research collaboration with MD Anderson Cancer Center to explore its nPulse™ ...

Summary • Gain Therapeutics, Inc. (GANX) rose 6.8% in pre-market trading to $4.22 without a clear catalyst.• The stock shows strong momentum with a 14-day RSI of 67.32 and substantial annual growth of ...

Summary • AMC Robotics Corporation (AMCI) shares surged 33.8% in pre-market trading, rising to $9.73.• The spike follows the ...

Summary • Genius Group Limited (GNS) shares climbed 5.5% in pre-market trading, raising prices to $0.6990 without a clear catalyst.• A class action lawsuit for alleged securities fraud has been filed, ...

Summary • Beasley Broadcast Group, Inc. (BBGI) shares drop 10% in pre-market trading to $5.22, signaling traders reassessing positions.• Recent insider sales, including Chief Accounting Officer Shaun ...

Summary • YY Group Holding Limited shares rise 5.7% in pre-market trading to $0.2369 amid leadership changes.• Ken Teng is promoted to Director of Southeast Asia to support growth in the region.• An 8 ...

Summary • Neo-Concept International Group Holdings Limited (NCI) dropped 12% in pre-market trading, reaching $1.27 from $1.45.• The decline occurred despite the absence of a clear catalyst and follows ...

Summary • Cineverse Corp. (CNVS) shares fell 9% in pre-market trading, down to $2.07 from $2.27, without a clear catalyst.• Recent film “Silent Night, Deadly Night” received positive reviews but ...